NeoDoppler
- ultrasound monitoring of neonates
NeoDoppler is a new ultrasound technology for continuous cerebral blood flow measurements in neonates. With the NeoDoppler technology, we aim to reduce the incidence of brain injury in premature infants and critically ill neonates.
Background
Premature infants and critically ill neonates face a heightened risk of brain injury during the initial hours and days of life. The NeoDoppler technology can detect variations in cerebral blood flow, allowing for timely interventions such as optimizing ventilator settings or adjusting blood pressure to prevent brain injury.
The small ultrasound probe is placed at the head of the baby and cerebral blood flow can be measured continuously. NeoDoppler do not disturb the child, the medical treatment, the nursing, or the parent's contact with their child.
NeoDoppler is user-independent and has considerable advantages over conventional ultrasound imaging, which provides only a snapshot of the brain circulation.
​
The NeoDoppler ultrasound system has been developed by Professor Hans Torp and the Ultrasound Group at the Department of Circulation and Medical Imaging, NTNU.
​
The first clinical study started in 2017 at the Neonatal Intensive Care Unit at St. Olavs Hospital.